Irinotecan Liposome Combined With Oxaliplatin and Tegafur as Adjuvant Therapy for Pancreatic Cancer
Conditions: Pancreatic Cancer; Adjuvant Therapy Interventions: Drug: Irinotecan liposome injection Sponsors: Kuirong Jiang; CSPC Ouyi Pharmaceutical Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Anti-PD-1/PD-L1 Combined With Anti-angiogenic Agents as First-line Treatment for Unresectable HCC
Conditions: Unresectable Hepatocellular Carcinoma Interventions: Drug: Adebrelimab plus Apatinib; Drug: Adebrelimab plus Bevacizumab; Drug: Camrelizumab plus Apatinib Sponsors: Peking University Cancer Hospital& Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
The Role of 68GA DOTATATE PET/CT In Breast Cancer Imaging
Conditions: Breast Cancer Interventions: Diagnostic Test: 18F FDG PET/CT; Diagnostic Test: 68Ga DOTATATE PET/CT Sponsors: Celal Bayar University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
A Study to Learn About How BAY2927088 Affects the Level of Midazolam in the Blood When Both Drugs Are Taken Together in Healthy Participants
Conditions: Advanced Non-small Cell Lung Cancer; EGFR Mutation; HER2 Mutation; Healthy Volunteers Interventions: Drug: BAY2927088; Drug: Midazolam Sponsors: Bayer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
A Study Evaluating AMG 193 in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion
Conditions: Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers Interventions: Drug: AMG 193; Drug: Gemcitabine; Drug: Nab-paclitaxel; Drug: Cisplatin; Drug: Pembrolizumab; Drug: Modified FOLFIRINOX Sponsors: Amgen Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Study of ST-1898 in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Cancer
Conditions: Differentiated Thyroid Carcinoma Interventions: Drug: ST-1898 tablets Sponsors: Beijing Scitech-Mq Pharmaceuticals Limited Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Fertility Preservation and Pregnancy and Offspring Health Outcomes in Female Cancer Patients: A Multicenter, Prospective, Cohort Study
Conditions: Fertility Issues; Cancer Interventions: Other: fertility preservation Sponsors: The First Affiliated Hospital with Nanjing Medical University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Efficacy and Toxicity of Docetaxel as a Radiosenstizer in Head and Neck Cancer
Conditions: Head and Neck Cancer Interventions: Drug: Docetaxel Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Testing Copanlisib as Potentially Targeting Treatment in Cancers With PTEN Loss (MATCH - Subprotocol Z1G)
Conditions: Malignant Solid Neoplasm Interventions: Procedure: Biopsy; Procedure: Biospecimen Collection; Drug: Copanlisib; Procedure: Radiologic Examination Sponsors: National Cancer Institute (NCI) Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
PD-1 Combined With Chemotherapy and PULSAR in LAPC and Local Recurrence Patients
Conditions: Pancreatic Cancer Interventions: Drug: PD-1; Drug: Nab-paclitaxel; Drug: Gemcitabine; Radiation: PULSAR Sponsors: Fudan University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Testing Crizotinib as Potentially Targeted Treatment in Cancers With MET Exon 14 Deletion Genetic Changes (MATCH - Subprotocol C2)
Conditions: Advanced Lymphoma; Advanced Malignant Solid Neoplasm; Refractory Lymphoma; Refractory Malignant Solid Neoplasm; Refractory Multiple Myeloma Interventions: Procedure: Biopsy; Procedure: Biospecimen Collection; Drug: Crizotinib; Procedure: Radiologic Examination Sponsors: National Cancer Institute (NCI) Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Prehabilitation Exercise Program in Breast Cancer: Effects on Quality of Life and Tumor Microenvironment (PEP_BC)
Conditions: Breast Cancer Interventions: Behavioral: Prehabilitation exercise program Sponsors: Institut Nacional d ' Educacio Fisica de Catalunya; ICFO - The Institute of Photonics Sciences; Hospital Clinic of Barcelona; Institut d ' Investigacions Biom èdiques August Pi i Sunyer; Universidad San Jorge Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Mobile Health App to Promote Participation of Black Women in Breast Cancer Clinical Trials
Conditions: Breast Cancer Interventions: Behavioral: Survey; Behavioral: mHealth app Sponsors: UNC Lineberger Comprehensive Cancer Center Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
a SIngle Center Study of Post-operative STEReotactic RAdiotherapY for Endometrial Cancer
Conditions: Endometrial Cancer Interventions: Radiation: Stereotactic Post-operative Radiotherapy for Endometrial Cancer Sponsors: ARNAS Civico Di Cristina Benfratelli Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
Ultra Low Dose CT and Use of Iomeron 400 in PCD-CT
Conditions: Radiation Exposure; Lung Embolism; Lung Cancer; Pneumonia Interventions: Radiation: Computed Tomography Sponsors: University of Zurich Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 11, 2024 Category: Research Source Type: clinical trials
